人类单克隆抗体可以防止病毒介导的肺炎球菌超级感染
Aaron Gingerich1, Lauren Mahoney1, Anna L McCormick1,2
1Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Frontiers in immunology
|June 27, 2024
概括
一种抗PhtD单克隆抗体 (mAb) 尾酒有效地治疗病毒和Streptococcus pneumoniae (Spn) 的共感染. 这种疗法改善了临床前模型中的生存率和减少了细菌负载,为抗生素耐药性提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 社区获得性肺炎 (CAP) 是一个重要的全球健康问题.
- 肺炎链球菌 (Spn) 导致25%的CAP病例.
- 病毒感染 (IAV,RSV,hMPV) 会增加二次SPN感染的风险.
研究的目的:
- 评估抗PhtD单克隆抗体 (mAb) 尾酒 (PhtD3+7) 在治疗病毒/细菌共感染中的疗效.
- 在临床前模型中评估生存率和细菌负载减少.
主要方法:
- 在三个共感染模型中测试了一种抗PhtD mAb尾酒 (PhtD3 + 7):IAV/Spn,hMPV/Spn和RSV/Spn.
- 对相关抗病毒药物的有效性进行比较mAbs.
主要成果:
- 在所有模型中,PhtD3 + 7 mAb尾酒改善了生存率,并降低了血液和肺部的细菌标位 (2-4日志).
- 它在hMPV/Spn和RSV/Spn模型中表现出优于或与抗病毒mAbs相当的疗效.
结论:
- 抗PhtD mAb疗法是治疗病毒性和二次性肺炎球菌共感染的有希望的策略.
- 这种方法为抗生素提供了潜在的替代品,解决了对抗生素耐药性的担忧.
相关概念视频
Hybridoma Technology
14.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.4K
Immune Response Against Viral Pathogens
771
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
771


